A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk

Breast Cancer Research and Treatment

Volumn 107, Issue 2, 2008, Pages 289-301

  Wakefield, Claire E ^a,b   Meiser, Bettina ^b,c   Homewood, Judi ^a   Peate, Michelle ^b   Taylor, Alan ^a   Lobb, Elizabeth ^d,e   Kirk, Judy ^f   Young, Mary Anne ^g   Williams, Rachel ^h   Dudding, Tracy ⁱ   Tucker, Kathy ^b,j   Barlow Stewart, K ^k   Fenton, G ^f   Goodwin, A ^f   Zodgekar, P ^f   Andrews, L ^b   Koeler, J ^b   Overkov, A ^b   Tyler, J ^b   Warner, B ^b   Gleeson, M ^l   Groombridge, C ^l   O'Donnell, S ^l   Spigelman, A ^l   McMahon, C ^a   Hossack, L ^g   Kentwell, M ^g   Aragona, C ^m   D'Souza, R ^m   Gaff, C ^m   Hodgkin, L ^m   Ward, R ^h   Butow, P ^e   Davey, H ^e   more..

^a MACQUARIE UNIVERSITY   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d EDITH COWAN UNIVERSITY   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f WESTMEAD HOSPITAL   (Australia)

^g PETER MACCALLUM CANCER CENTRE   (Australia)

^h ST VINCENT S HOSPITAL   (Australia)

ⁱ Hunter Family Cancer Service   (Australia)

^j UNIVERSITY OF NEW SOUTH WALES   (Australia)

^k Centre for Genetics Education   (Australia)

^l Hunter Genetics   (Australia)

^m ROYAL MELBOURNE HOSPITAL   (Australia)

more..

Author keywords

Decision aid; Genetic testing; Hereditary breast cancer; Hereditary ovarian cancer; Patient education

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD; BREAST CANCER; CANCER RISK; CONSULTATION; CONTROLLED STUDY; DECISION MAKING; FAMILY; FEMALE; GENETIC ANALYSIS; GENETIC COUNSELING; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT;

ADULT; AGED; BREAST NEOPLASMS; DECISION SUPPORT TECHNIQUES; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MIDDLE AGED; MODELS, GENETIC; OVARIAN NEOPLASMS; PATIENT EDUCATION AS TOPIC; QUESTIONNAIRES; RISK;

EID: 37249025159     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9539-2     Document Type: Article

References (49)

1. International Breast Cancer Intervention Study Investigators (2002) First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360:817-824
2. Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77-84
3. Scheuer L, Kauff N, Robson M et al (2002) Outcome and preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 20:1260-1268
4. Meijers-Heijboer H, Van Geel B, Van Putten W et al (2001) Breast cancer after prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159-164
5. Levy-Lahad E, Friedman E (2007) Cancer risks among BRCA1 and BRCA2 mutation carriers. BJC 96:11-15
6. Lodder LN, Frets PG, Trijsburg RW et al (2002) One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 73:97-112
7. Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676-689
8. National Health and Medical Research Council (1999) Familial aspects of cancer: A guide to clinical practice. National Health and Medical Research Council, Canberra, November 1999
9. Meiser B (2005) Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 14:1060-1074
10. van Dijk S, Otten W, Timmermans DR et al (2005) What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer. Genet Med 7:239-245
11. van Dijk S, Timmermans DRM, Meijers-Heijboer H et al (2006) Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. J Clin Oncol 24:3672-3677
12. Ropka M, Wenzel J, Phillips E et al (2006) Uptake rates for breast cancer genetic testing: a systematic review. Cancer Epidemiol Biomarkers Prev 15:840-855
13. O'Connor AM, Mulley AG Jr, Wennberg JE (2003) Standard consultations are not enough to ensure decision quality regarding preference-sensitive options. J Natl Cancer Inst 95:570-571
14. O'Connor AM, Rostom A, Fiset V et al (1999) Decision aids for patients facing health treatment or screening decisions: systematic review. BMJ 319:731-734
15. O'Connor A, Tugwell P, Welles GA et al (1998) Randomized trial of a portable, self-administered decision aid for postmenopausal women considering long-term preventative hormone replacement therapy. Med Decis Making 18:295-303
16. O'Connor AM (1999) Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst 25:67-80
17. Elwyn G, O'Connor A, Stacey D et al (2006) Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 333:417
18. Wakefield CE, Meiser B, Homewood J et al (in press) Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk. J Genet Couns
19. Australian Cancer Network (1999) Guidelines on familial aspects of cancer. Australian Cancer Network, Sydney, November 1999
20. National Breast Cancer Centre (2000) Current best advice about familial aspects of breast/ovarian cancer. NHMRC National Breast Cancer Centre, Sydney, 2000
21. Centre for Genetics Education (2007) Centre for Genetics Education. http://www.genetics.com.au/. Cited 19 Jan 2007
22. O'Connor AM, Stacey D, Entwistle V et al (2006) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 1:1
23. Rimer BK, Glassman B (1999) Is there a use for tailored print communications in cancer risk communication? J Natl Cancer Inst 25:140-148
24. Bastani R, Maxwell A, Bradford C et al (1999) Tailored risk notification for women with a family history of breast cancer. Prev Med 29:355-364
25. O'Connor AM (1995) Validation of a decisional conflict scale. Med Decis Making 15:25-30
26. Michie S, Dormandy E, Marteau TM (2002) The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns 48:87-91
27. Horowitz MJ, Wilner N, Alvarez W (1979) Impact of event scale: a measure of subjective stress. Psychosom Med 41:209-218
28. Thewes B, Meiser B, Hickie IB et al (2001) Psychometric properties of the impact of event scale amongst women at increased risk for hereditary breast cancer. Psychooncology 10:459-468
29. Zigmond A, Snaith R (1983) The hospital anxiety and depression scale. Psychiatr Scand 67:361
30. Hall A, A'Hern R, Fallowfield L (1999) Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer 35:79-85
31. Johnston M, Pollard B, Hennessey P (2000) Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 48:579-584
32. Ibbotson T, Maguire P, Selby P et al (1994) Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 30A:37-40
33. Brehaut JC, O'Connor AM, Wood TJ et al (2003) Validation of a decision regret scale. Med Decis Making 23:281-292
34. SPSS Inc. (2005) Statistical Program for the Social Sciences: Release 14.0. SPSS Inc., Chicago, IL
35. StataCorp (2005) Stata Statistical software: Release 9.0. StataCorp, College Station, TX
36. Williams RL (2000) A note on robust variance estimation for cluster-correlated data. Biometrics 56:645-646
37. Bekker HL, Legare F, Stacey D et al (2003) Is anxiety a suitable measure of decision aid effectiveness: a systematic review? Patient Educ Couns 50:255-262
38. Botkin JR, Smith KR, Croyle RT et al (2003) Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing. Am J Med Genet A 118:201-209
39. Cull A, Anderson EDC, Campbell S et al (1999) The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. BJC 79:501-508
40. Lerman C, Narod S, Schulman K et al (1996) BRCA1 testing in families with hereditary breast-ovarian cancer. JAMA 275:1885-1892
41. Meijers-Heijboer EJ, Verhoog LC, Brekelmans CT et al (2000) Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 335:2015-2020
42. O'Neill SM, Peters JA, Vogel VG et al (2006) Referral to cancer genetic counseling: are there stages of readiness? Am J Med Genet C 142:221-231
43. Mancini J, Nogues C, Adenis C et al (2006) Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing. Eur J Cancer 42:871-881
44. Mireskandari S, Meiser B, Sherman K et al (2006) Evaluation of the needs and concerns of partners of women at high risk of developing breast/ovarian cancer. Psychooncology 15:96-108
45. Manne S, Audrain J, Schwartz M et al (2004) Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample. Ann Behav Med 28:211-225
46. Schwartz MD, Lerman C, Brogan B et al (2005) Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev 14:1003-1007
47. Australian Bureau of Statistics (2006) Australian social trends 2006. Australian Bureau of Statistics, Canberra
48. Meiser B, Butow P, Friedlander M et al (2002) Psychological impact of genetic testing for women for breast cancer susceptibility. Eur J Cancer 38:2025-2033
49. Tiller K, Meiser B, Gaff C et al (2006) A randomized controlled trial of a decision aid for women at increased risk of ovarian cancer. Med Decis Making 26:360-372